In certain patients, anti-nuclear antibody may play a role.

On anti-nuclear antibody tests, these antigens have a speckled pattern.

Of the antibodies, 90% have a detectable anti-nuclear antibody.

Anti-Jo1 antibodies are a type of anti-nuclear antibody.

Unlike in SLE, an anti-nuclear antibody test is usually negative.

Anti-nuclear antibodies appear to be prognostic agents in PBC.

The development of anti-nuclear antibodies (ANA) has been found in 10 to 30% of patients under treatment with acebutolol.

The appearance of anti-nuclear antibodies in autoimmune hepatitis was found to correlated with A1-B8-DR3.

Centromere proteins are also the autoantigenic target for some anti-nuclear antibodies, such as anti-centromere antibodies.

Since this activity occurs in the nucleus of the cell ATA is a form of anti-nuclear antibody.

A prominent humoral abnormality in SSc is manifested by the presence of anti-nuclear antibodies [ 5].

Anti-nuclear antibody (ANA)

Rheumatoid factor (RF) and anti-nuclear antibody (ANA) were negative.

Distinguishing laboratory characteristics are a positive, speckled anti-nuclear antibody and an anti-U1-RNP antibody.

These are known as anti-nuclear antibodies (ANA) and have also been observed in concert with multiple sclerosis as part of general immune system dysfunction.

These are called anti-mitochondrial antibodies (AMA) and anti-nuclear antibodies (ANA), respectively.

The kinetoplast found in C.luciliae allows them to be used for the detection of anti-dsDNA antibodies, a type of anti-nuclear antibody.

Anti-dsDNA antibodies are a group of anti-nuclear antibodies and their target antigen is double stranded DNA.

Recognized by anti-nuclear antibodies found in primary biliary cirrhosis (PBC) anti-Nup210 antibodies correlate with progression toward end stage liver disease.

Anti-nuclear antibodies are a common feature in SLE and anti-dsDNA antibodies are highly specific for the disease.

This type affects fewer than four joints (usually the large joints such as knees, ankles or wrists) and may cause eye inflammation in girls with positive anti-nuclear antibodies (ANA).

Anti-nuclear antibodies (ANAs, also known as anti-nuclear factor or ANF) are autoantibodies that bind to contents of the cell nucleus.

However, laboratory tests may also help in discovering inflammation by checking C-reactive protein level, erythrocyte sedimentation rate, level of peripheral leukocytes, ferritin level, anti-nuclear antibodies level, and rheumatoid factor status.

DQ7.6 is positively associated with asthma, pauciarticular juvenile arthritis without anti-nuclear antibodies, DQ7.6 is negatively associated (Protective against) juvenile diabetes, liver and spleen disease in Schistosoma japonicum infection, pulmonary tuberculosis.

Blood tests can be done to determine if a patient has high levels of antibodies that are indicative of the condition, such as anti-nuclear antibody (ANA) and rheumatoid factor (because SS frequently occurs secondary to rheumatoid arthritis), which are associated with autoimmune diseases.